During trading, Yao Ph.D. Holdings (02192) rose over 17%, and at the time of writing, it had risen by 10.16%, closing at HKD 7.59 with a turnover of HKD 11.3699 million.
According to the Zhītōng Cáijīng APP, Yao Ph.D. Holdings (02192) rose over 17% during trading, and at the time of writing, it had risen by 10.16%, closing at HKD 7.59 with a turnover of HKD 11.3699 million.
On the news front, the National Comprehensive Cancer Network (NCCN) of the USA announced a strategic cooperation with Yao Ph.D. Holdings, expanding the accessibility of China's well-known oncology guidelines and providing critical resources for Chinese medical professionals and patients in cancer care.
As of June of this year, NCCN has over 1.9 million registered users, with China being the second-largest country in terms of users, following only the USA. Cancer-related care guidelines are downloaded over 0.85 million times annually, with many users downloading them through the Yao Ph.D. platform.